Loading
Journal Status
Acceptance Rate62 %
Submission to final decision30 days
Acceptance to publication15 days
Cite Score2.32
Submit
Author guidelines
Editorial Board
Databases and Indexing
Journal Status
Acceptance Rate62 %
Submission to final decision30 days
Acceptance to publication15 days
Cite Score2.32
Submit
Author guidelines
Editorial Board
Databases and Indexing
Journal profile

Journal of Immunology and Allergy (ISSN: 2582-6549) is an open-access journal intended to publish cutting-edge research in the field of Immunology and Allergy. Journal intends to publish clinical and translational research papers for allergists, immunologists, dermatologists, gastroenterologists, and other physicians and researchers interested in allergic diseases and clinical immunology.

Editor spotlight

Editor in Chief - Dr. Giuseppe Murdaca, is currently working as an Assistant professor at the Internal Medicine University of Genova, Italy. Previously he served as Associate Professor in Internal Medicine University of Genova, Italy. He received his Ph.D. in Science and Space Engineering at the University of Genova, Italy.

Special Issues

We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field or provide a venue for a deeper investigation into an existing research area.

Latest Articles

Research Article Nov 26, 2022
Criteria for Accepting or Rejecting Cord Blood Units

Khalid Kazim*, Hatim Al Abbas and Fatima Al Kamali

Dubai Cord Blood and Research Center (DCRC), Dubai Academic Health Corporation (DAHC), Dubai, UAE

*Corresponding Author: Kazim K, Senior Specialist Immunologist, Head of processing and cryogenic labs, Dubai Cord Blood and Research Center (DCRC), Dubai, UAE.

Research Article Nov 21, 2022
Hepatitis B and C Co-Infection among HIV-Positive Patients Attending Art at General Hospital Kaltungo, Gombe State, Nigeria

Nengak D Precious1*, Olaniru B Olumide2, Selowo T Temitope2, Ariyo T Seth1, Bulus A Dawa1, Bigwan T Yanan1 and Alaike Vivian Ogechi1

1Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, University of Jos, Plateau State, Nigeria

2Department of Chemical Pathology, Jos University Teaching Hospital Jos, Plateau State, Nigeria

*Corresponding Author: Danladi Nengak Precious, Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, University of Jos, Plateau State, Nigeria.

Research Article Oct 28, 2022
Clinical Significance Of Serum And Urine Soluble Interleukin 2 Receptor, C-Reactive Protein, Cystatin C, and Serum and Urine Creatinine in Renal Transplant Patients

Khalid Kazim*

1Senior Specialist Immunologist, Head of processing and cryogenic labs, Dubai Cord Blood and Research Center (DCRC), Dubai, UAE

*Corresponding Author: Kazim Khalid Senior Specialist Immunologist, Head of processing and cryogenic labs, Dubai Cord Blood and Research Center (DCRC), Dubai, UAE.

Review Article Oct 27, 2022
Functional and Cellular Immunotherapy (FCIT) Concept

Khalid Kazim1*, Peter Friedrichsen2 and Sean Ng3

1Senior Specialist Immunologist/FCIT Concept, Dubai, UAE

2Orthomolecular/Functional Medicine/Environmental Medicine, Freiburg, Germany

3Regenerative Medicine, Kuala Lumpur, Malaysia

*Corresponding Author: Khalid Kazim, Senior Specialist Immunologist/FCIT Concept, Dubai, UAE.

Review Article Oct 27, 2022
Should the First Rejected Kidney Implant be Removed?

Khalid Kazim*

Senior Specialist Immunologist, Head of processing and cryogenic labs, Dubai Cord Blood and Research Center (DCRC), Dubai, UAE

*Corresponding Author: Kazim Khalid, Senior Specialist Immunologist, Head of processing and cryogenic labs, Dubai Cord Blood and Research Center (DCRC), Dubai, UAE.

Review Article Sep 16, 2022
What Causes ME/CFS: The Role of the Dysfunctional Immune System and Viral Infections

Amolak S Bansal1*, Aletta D Kraneveld2, Elisa Oltra3 and Simon Carding4

1Consultant in Immunology, Allergy and CFS/ME, Spire Bushey Hospital, Watford, UK

2Chair Interdisciplinary Translational Pharmacology, Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht the Netherlands

3Department of Pathology, Faculty of Medicine and Health Sciences, Catholic University of Valencia, Valencia, Spain

4Gut Microbes & Health, Quadram Institute Bioscience, Norwich Research Park, Norwich, NR4 7UQ, UK and Norwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK

*Corresponding Author: Amolak S Bansal,Consultant in Immunology, Allergy and CFS/ME, Spire Bushey Hospital, Watford, UK.

Review Article Aug 29, 2022
Anti-inflammatory Action of the Treated-Yeast, Milmed, Under IBS-IBD Conditions

Trevor Archer1*, Rose Mary Erixon2, Thomas Lenz1 and Rita Businaro3

1Milmed Unico AB, Regeringsgatan 93, Stockholm, Sweden

2University ofGothenburg, Department of Psychology, Gothenburg, Sweden

3Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy

*Corresponding Author: Trevor Archer, Milmed Unico AB, Regeringsgatan 93, Stockholm, Sweden.

Review Article Jul 29, 2022
Prevention Risks of Post Covid-19 Infection and Rebound Symptoms

Howard B Reinfeld1*

1Cardiology Graduate of Mount Sinai Hospital Miami Beach Florida and Cardiologist at Private Practice, Howard B Reinfeld and Associates MD, PA, and B.S Pharmacy, St. John’s University, Jamaica, New York, USA

*Corresponding Author: Howard B Reinfeld, Cardiology Graduate of Mount Sinai Hospital Miami Beach Florida and Cardiologist at Private Practice, Howard B Reinfeld and Associates MD, PA, and B.S Pharmacy, St. John’s University, Jamaica, New York, USA.